A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy

Radiotherapy and Oncology

Volumn 76, Issue 1, 2005, Pages 11-17

  Nichol, Alan ^a   Chung, Peter ^a   Lockwood, Gina ^a   Rosewall, Tara ^a   Divanbiegi, Lorella ^a   Sweet, Joan ^b   Toi, Ants ^c   Bayley, Andrew ^a   Bristow, Rob ^a   Crook, Juanita ^a   Gospodarowicz, Mary ^a   McLean, Michael ^a   Milosevic, Michael ^a   Warde, Padraig ^a   Catton, Charles ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE TOXICITY; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CHRONIC TOXICITY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; GASTROINTESTINAL TOXICITY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; QUESTIONNAIRE; RADIATION DOSE; RADIATION INJURY; UROGENITAL TRACT DISEASE;

ADENOCARCINOMA; AGED; BIOPSY; DISEASE-FREE SURVIVAL; HUMANS; INTESTINES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SURVIVAL RATE; URINARY BLADDER;

EID: 23244455017     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.06.002     Document Type: Article

References (31)

1. American Society for Therapeutic Radiology and Oncology Consensus Panel Consensus statement: guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 37 1997 1035 1041
2. J. Cox, J. Stetz, and T. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
3. J. Crook, Y. Bahadur, S. Robertson, G. Perry, and B.A. Esche Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma Cancer 79 1997 81 89
4. J. Crook, B. Esche, and N. Futter Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective Urology 47 1996 317 394
5. J. Crook, S. Malone, G. Perry, Y. Bahadur, S. Robertson, and M. Abdolell Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys 48 2000 355 367
6. J. Crook, G. Perry, S. Robertson, and B. Esche Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients Urology 45 1995 624 632
7. A.V. D'Amico, J. Manola, M. Loffredo, A.A. Renshaw, A. DellaCroce, and P.W. Kantoff 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial J Am Med Assoc 292 2004 821 827
8. D. Dearnaley, V. Khoo, and A. Norman Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial Lancet 353 1999 267 272
9. D.P. Dearnaley, E. Hall, and D. Lawrence Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects Br J Cancer 92 2005 488 498
10. B.G. Gardner, A.L. Zietman, W.U. Shipley, U.E. Skowronski, and P. McManus Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer J Urol 167 2002 123 126
11. E. Geary, T. Dendinger, F. Freiha, and T. Stamey Nerve sparing radical prostatectomy: a different view J Urol 154 1995 145 149
12. G.E. Hanks, A.L. Hanlon, B. Epstein, and E.M. Horwitz Dose response in prostate cancer with 8-12 years' follow-up Int J Radiat Oncol Biol Phys 54 2002 427 435
13. A. Hanlon, T. Schultheiss, M. Hunt, B. Movsas, R. Peter, and G. Hanks Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales Int J Radiat Oncol Biol Phys 38 1997 59 63
14. ICRU. ICRU 50: prescribing, recording and reporting photon beam therapy. Bethesda MD: ICRU 1993.
15. Kattan M. Kattan Nomogram, ed. Palm Pilot v4.02 (OS4); 2004
16. W. Lee, G. Hanks, A. Hanlon, T. Schultheiss, and M. Hunt Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect Int J Radiat Oncol Biol Phys 35 1996 251 257
17. M. Liu, T. Pickles, and A. Agranovich Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy Int J Radiat Oncol Biol Phys 58 2004 59 67
18. H. Lukka, P. Warde, and T. Pickles Controversies in prostate cancer radiotherapy: consensus development Can J Urol 8 2001 1314 1322
19. J. Michalski, J. Purdy, and K. Winter Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406 Int J Radiat Oncol Biol Phys 46 2000 391 402
20. C. Parker, T. Haycocks, A. Bayley, H. Alasti, P. Warde, and C. Catton A dose-volume histogram analysis of the seminal vesicles in men treated with conformal radiotherapy to 'prostate alone' Clin Oncol (R Coll Radiol) 14 2002 298 302
21. A. Pollack, G. Zagars, J. Antolak, D. Kuban, and I. Rosen Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial Int J Radiat Oncol Biol Phys 54 2002 677
22. A. Pollack, G. Zagars, and G. Starkschall Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105
23. L.H. Sobin, and C. Wittekind UICC TNM classification of malignant tumours 5th ed 1997 Wiley-Liss New York
24. M. Storey, A. Pollack, G. Zagars, L. Smith, and J. Antolak Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomised trial Int J Radiat Oncol Biol Phys 48 2000 635 642
25. J. Talcott, P. Rieker, and K. Propert Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy J Natl Cancer Inst 89 1997 1117 1123
26. J. Trachtenberg, J. Chen, W. Kucharczyk, A. Toi, and C. Lancaster Microwave thermoablation for localized prostate cancer after failed radiation therapy: role of neoadjuvant hormonal therapy Mol Urol 3 1999 247 250
27. R.K. Valicenti, K. Winter, and J.D. Cox RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? Int J Radiat Oncol Biol Phys 57 2003 614 620
28. M. Zelefsky, D. Cowen, and Z. Fuks Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma Cancer 85 1999 2460 2468
29. M. Zelefsky, Z. Fuks, and M. Hunt High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J Urol 166 2001 876 881
30. M. Zelefsky, Z. Fuks, and M. Hunt High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients Int J Radiat Oncol Biol Phys 53 2002 1111 1116
31. A. Zietman, M. DeSilvio, and J. Slater A randomised trial comparing conventional dose (70.2 GyE) and high dose (79.2 GyE) conformal radiation in early stage adenocarcinoma of the prostate: results of an interim analysis of PROG 95-09 Int J Radiat Oncol Biol Phys 2004 [ASTRO suppl: Abstract 4]